Delivery Order SPE2DB24D3013-SPE2DB25FFMTN
Award Date
6/23/25
Potential Completion Date
6/24/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,885.07 contract is for the delivery of Lisdexamfetamine 40 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of May 20, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lisdexamfetamine 40 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a ceiling value of $1,416.59 and a performance period extending through June 24, 2025. It is a firm-fixed-price contract and does not have a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lisdexamfetamine 30 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a ceiling value of $1,162.22 and a completion date of June 23, 2025. It is a firm fixed-price contract, indicating a pre-determined price for the items....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Lisdexamfetamine 30 mg capsules, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). The contract has a ceiling value of $8,520.42 and a performance period extending through June 2025. This is a firm fixed-price contract without any set-aside...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 20 mg capsules of the drug lisdexamfetamine, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a Firm Fixed Price award with a ceiling value of $3,249.17 and a completion date of June 6, 2025. This award is not designated as a set-aside contract....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lisdexamfetamine 20 mg capsules, a medication commonly used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a ceiling value of $6,122.59 and is a firm fixed-price contract with a period of performance ending on May 5, 2025. This contract is not set aside for any...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,287.68, is for the delivery of 4,567,956,474 units of the prescription medication lisdexamfetamine 40 mg capsules. The contract is a firm fixed-price, non-set-aside arrangement with an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 10 mg capsules of the medication lisdexamfetamine, a common treatment for ADHD, with a ceiling value of $2,060.30. The contract is a Firm Fixed Price arrangement with a performance period ending on June 10, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,247.04 firm fixed-price delivery order is for the supply of 4,567,057,343 units of 20 mg Lisdexamfetamine capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of January 28, 2025 and was awarded on January 27, 2025. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The contract is for the delivery of Lisdexamfetamine 70 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a delivery order valued at $5,456.55 with a firm fixed price, and has an ultimate completion date of June 11,...